Loading clinical trials...

A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05535959

A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor

The purpose of this study is to evaluate the relative bioavailability of a fixed-dose combination tablet (FDC) of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA).

Lead sponsor: Vertex Pharmaceuticals Incorporated•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis

RECRUITINGPhase 2

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis

RECRUITINGPhase 1

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NCT06154447 · Cystic Fibrosis

RECRUITINGPhase 3

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

NCT05422222 · Cystic Fibrosis

RECRUITING

Physical Impairments in Children With Cystic Fibrosis

NCT06984679 · Cystic Fibrosis (CF), Cystic Fibrosis in Children

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 12, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment16

Start dateSep 2022

Last updatedDec 12, 2022

Condition

Cystic Fibrosis

Locations shown

ICON Salt Lake City

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions